H Poort,
ATHR Fenton, E Thompson, MM Dinardo… - Gynecologic …, 2021 - Elsevier
Abstract Objective Oral PARP inhibitors (PARPi) have dramatically changed the treatment
landscape for patients with advanced ovarian cancer. However, a subset of patients …